Real World Effectiveness and Safety of Ticagrelor and Prasugrel as Compared With Clopidogrel Are Inconsistent With the Findings From Clinical Trials

被引:0
|
作者
Yuan, Zhong
Plotnikov, Alexei N.
Weaver, James
Londhe, Ajit
Barnathan, Elliot
Strony, John
机构
关键词
Myocardial infarction; Ischemic stroke; Acute coronary syndromes; Pacemaker; artificial;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
15443
引用
收藏
页数:2
相关论文
共 50 条
  • [21] GetReal: from efficacy in clinical trials to relative effectiveness in the real world
    Egger, Matthias
    Moons, Karel G. M.
    Fletcher, Christine
    RESEARCH SYNTHESIS METHODS, 2016, 7 (03) : 278 - 281
  • [22] COMPARED THE CLINICAL OUTCOMES OF CLOPIDOGREL AND TICAGRELOR IN STABILIZED PATIENTS WITH ACUTE CORONARY SYNDROME AFTER PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A REAL-WORLD REGISTRY
    Zhang, Yunnan
    Han, Jialun
    Shi, Xiujin
    Peng, Wenxing
    Lin, Yang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1030 - 1030
  • [23] Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis
    Rodriguez, Alfredo E.
    Rodriguez-Granillo, Alfredo M.
    Ascarrunz, Sergio D.
    Peralta-Bazan, Francisco
    Cho, Mi Y.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (04) : 465 - 477
  • [24] REAL-WORLD EFFICACY AND SAFETY OF DUAL ANTIPLATELET THERAPY WITH TICAGRELOR AS COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
    Wiens, Evan
    Leon, Silvia J.
    Whitlock, Reid
    Tangri, Navdeep
    Shah, Ashish
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1032 - 1032
  • [25] Safety and efficacy of in-hospital clopidogrel-to-prasugrel switching in patients with acute coronary syndrome. An analysis from the 'real world'
    Almendro-Delia, Manuel
    Blanco Ponce, Emilia
    Gomez-Dominguez, Rocio
    Gonzalez-Matos, Carlos
    Lobo-Gonzalez, Manuel
    Caballero-Garcia, Auxiliadora
    Hidalgo-Urbano, Rafael
    Jose Cruz-Fernandez, Maria
    Garcia-Rubira, Juan C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (04) : 499 - 507
  • [26] Safety and efficacy of in-hospital clopidogrel-to-prasugrel switching in patients with acute coronary syndrome. An analysis from the ‘real world’
    Manuel Almendro-Delia
    Emilia Blanco Ponce
    Rocío Gomez-Domínguez
    Carlos Gonzalez-Matos
    Manuel Lobo-Gonzalez
    Auxiliadora Caballero-Garcia
    Rafael Hidalgo-Urbano
    Maria Jose Cruz-Fernandez
    Juan C. Garcia-Rubira
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 499 - 507
  • [27] DE-ESCALATION FROM PRASUGREL OR TICAGRELOR TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    Shehata, Joseph
    Abdelazeem, Basel
    Abbas, Kirellos Said
    El-Shahat, Nahla Ahmed
    Baral, Nischit
    Adhikari, Govinda
    Khan, Hafiz
    Hassan, Mustafa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 3471 - 3471
  • [28] Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention (vol 6, e000951, 2019)
    Krishnamurthy, A.
    Keeble, C.
    Anderson, M.
    OPEN HEART, 2019, 6 (02):
  • [29] 2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry
    Pol, D.
    Chowdhury, E.
    Delacroix, S.
    Worthley, S.
    Eccleston, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1731 - 1731
  • [30] De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials
    Abdelazeem, Basel
    Shehata, Joseph
    Abbas, Kirellos Said
    El-Shahat, Nahla Ahmed
    Baral, Nischit
    Adhikari, Govinda
    Khan, Hafiz
    Hassan, Mustafa
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 287 - 298